1,5-Anhydro-D-glucitol (AG; popularly called 1-deoxyglucose) has a pyranoid structure, resulting from the deletion of an oxygen from glucose at the anomeric hydroxyl group (see Figure 1 ). This compound is one of the main sugar alcohols in human cerebrospinal fluid (1) and serum (2). In plasma, the concentration of AG is reduced specifically in diabetes mellitus (2-4), thus ninking it useful as a diagnostic marker for the disease (5).
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1,5-Anhydro-D-glucitol
(AG; popularly called 1-deoxyglucose) has a pyranoid structure, resulting from the deletion of an oxygen from glucose at the anomeric hydroxyl group (see Figure 1 ). This compound is one of the main sugar alcohols in human cerebrospinal fluid (1) and serum (2). In plasma, the concentration of AG is reduced specifically in diabetes mellitus (2-4), thus ninking it useful as a diagnostic marker for the disease (5).
The most reliable method for AG assay has been gasliquid chromatography (GLC) (4, 6, 7); however, GLC is tedious and time-consuming and does not seem to be suitable as a clinical tool for diagnosis. We have therefore developed a simpler and more rapid analytical method involving enzymatic reactions. Screening microorganisms for AG-oxidizing enzymes revealed several suitable enzymes (8,9). Of these, we selected glucose 2-oxidase (pyranose oxidase, PROD; EC 1.1.3.10) because of its relative stability and its appreciable activity toward AG.
Here we report an effective use of PROD for determining AG in plasma. PrIncIple Figure 1 illustrates how PROD catalyzes the oxidation of AG at 2-OH with molecular oxygen to l,5-anhydro-Dfructose and H202. The resulting H2O2 is spectrophotometrically determined after a color development reaction with 2,2'-azino-bis(3-ethylbenzthiazoline-6-sulfonic acid) (ABTS) catalyzed by horseradish peroxidase (HRP; EC 1.11.1.7).
MaterIals and Methods
Materials
Reagents. AG and ABTS were purchased from Sigma Chemical Co., St. Louis, MO. PROD (specific activity for glucose: 5 U/mg of lyophilized material, 11.4 U/mg of protein) was from Takara Shuzo Co., Ltd., Kyoto, Japan. HRP (specific activity: >100 U/mg) was from Wako Pure Chemical Industry Ltd., Osaka, Japan. Other reagents were obtained from commercial sources and were of analytical grade.
Mini-columns. Ion-exchange resins AG 1 x 8 and AG 50W x 8 (Bio-Rad Laboratories, Richmond, CA) were packed into column reservoirs (Analytichem International, Harbor City, CA) to form two layers: 100 L of AG 50W x 8 (H form) was the lower layer and 400 zL of AG 1 X 8 (OH-form) was the upper layer. We washed the packed columns with about 2 mL of water, ifiled up the open space of each column with about 1 mL of water, sealed the top and bottom with sealing tape, then stored them at 4#{176}C until use. The water was removed just before use.
Buffers. Four series of buffer solutions (0.1 molIL, pH 4.5-6.0) were made from the following pairs of solutions: citric acid-Na2HPO4 (citrate-phosphate buffer), NaH2PO4-Na2HPO4 (phosphate buffer), citric acidsodium acetate (citrate-acetate buffer), and acetic acidsodium acetate (acetate buffer).
Stock solutions for optimum conditions. Except otherwise mentioned, the reaction mixture Blood samples were obtained from the diabetic section of a general hospital and used in accuracy studies. Peripheral venous blood was collected in heparinized vials. The plasma was separated by centrifugation immediately after the collection and stored at -20 #{176}C until analysis.
Procedures
Kinetic method. The reaction was carried out at 37#{176}C in a 10-mm-pathlength cuvette containing phosphate buffer (67 mmol/L, pH 5.6), a substrate (1 g/L), PROD (0.5 mg/L), HRP (3 kUIL), and ABTS (1 mmol/L). The reaction was started by adding the substrate solution and was monitored by reading the absorbance at 420 nm. We tested several sugars and expressed results as a percentage of that for AG.
AG assay. Vortex-mix 200 L of plasma sample and 15 1zL of trichloroacetic acid (600 g/L), then centrifuge. Apply 100 pL of the resulting supernate to the mini-column, elute the column four times with 500 zL of distilled water each time. Combine the eluates and add to 500 pL of the AG-detecting solution: 2 g of PROD, 240 U of HRP, and 4 mmol of ABTS per liter of phosphate buffer (0.25 mol/L, pH 5.6). The pH of resulting reaction mixture was 5.9. Incubate the color-developing mixture at 37 #{176}C for 1 h and measure its absorbance at 420 nm against a water reference.
Accuracy studies. In analytical-recovery studies, four plasma samples with known concentrations of AG were selected from stored clinical samples, and added to onetenth volume of AG solution of known concentration. We then measured the concentration of AG in these samples by our proposed method. Interference studies were performed by adding one-tenth volume of serially diluted solutions of substances known to usually affect the clinical colorimetric method.
Gas-liquid chromatography (GW). For comparison, we also assayed the blood samples by GLC (7). In brief, we added 100 zL of a venous plasma sample to 100 L of a 50 mg/L solution of an internal standard, xylitol, then deproteinized the sample with 20 times its volume of ethanol. The ethanolic extract was dried with a centrifugal evaporator and the hydrophobic materials were removed by partition between water and chloroform. The aqueous layer was separated and evaporated, and the resulting residue was acetylated in 300 L of acetic anhydride/pyridine solution (1/2 by vol). After extracting the resulting acetylated material with ether, we subjected it to isothermic GLC (203 #{176}C) on SP 2340/Chromosorb W-AW-DMCS packed in a 2-rn glass column. The gas chromatograph was a Model GC-4BM (Shimadzu Seisakusho, Ltd., Kyoto, Japan).
Results and Discussion
Optimization of Enzyme Reaction
We examined the effects of pH, sort of buffer, and the concentration of all the components involved in the enzyme reactions and constituting the system of an equilibrium method for AG determination.
To determine the suitable concentration of all the components, each stock solution was serially diluted with water and added to the reaction mixture.
Buffers
and pH. Because the optimum pH for PROD is 5.6, we chose four buffers (100 mmol/L) with buffering range from pH 5 to 6, and examined the effects of pH and Figure 3C ). Time course of reaction. To determine the optimal pH, we selected three pH points and examined the time course of the color-developing reaction at the optimized concentration of each reagent. The color formed by the reaction was the most stable at pH 5.2, but took the longest time to reach the maximum absorbance, and the reacting solution became turbid when an impure PROD preparation was used in the color-developing reaction (Figure 4) . At pH 6.4, the absorbance increased much faster but the resulting color was unstable. At pH 5.9, the color was relatively stable, and the solution remained clear even when the PROD with low purity was used; at this pH, the reaction reached equilibrium within 60 mm.
Calibration Curve and Sensitivity of Enzymatic Method
To know the linear range of calibration curve, we reacted AG standard solutions at various concentrations as described in the AG assay section. Instead of deproteinized plasma, however, we directly assayed 100 pL of a serially diluted AG standard solution without column treatment. The linear range of the calibration curve extended up to 50 mgIL, which covers the range of human plasma AG concentrations most likely to be encountered. The linear regression formula of absorbance (y) vs concentration of AG (x) wasy = 0.0112x + 0.0375 (r = 0.99996). The lower limit of detection was determined by assaying AG standard solutions of 0 to 3 mg/L (n = 5). AG concentrations of 0.5 and 1 mg/L corresponded to blank-corrected absorbances of 0.0046 and 0.0106, with CV values 47.0% and 4.2%, respectively. The detection limit of AG was 1 mg/L, as defined by a CV '10%.
Specificity of the Enzymatic Method
Substrate specificity of PROD. The substrate specificity of PROD was examined by a kinetic method (Table 1) Table 1 shows the similarity with reported activities of PROD toward a wide variety of sugars (9,10). The present study, however, demonstrates the activity of PROD toward a sugar alcohol for the first time. AG showed 18.5% reactivity of glucose in the oxidative reaction, and was the only sugar alcohol susceptible to PROD among those observed in plasma.
Equilibrium method. The AG concentration in human plasma is generally in the range from 1 to 40 mg/L, much lower than the concentration of glucose in plasma being measured by an enzymatic method. For substrates in such low concentrations equilibrium methods are generally preferable to kinetic methods. To check the reaction time needed in the equilibrium method, we followed the time course of the reaction for the 60 mg/L AG standard solution (Figure 4, solid line) . The reaction time of 60 mm seemed long enough to assure completion of the color-developing reaction.
A linear temporal increment of absorbance was observed only within a few minutes after the initiation of the reaction (Figure 48 ), the rate of increment being about 0.0007/mm for 1 mg of AG per liter. This corresponds to about 6% of the absorbance change obtained in the equilib- rium method. Therefore, the kinetic method seemed disadvantageous for such small changes of absorbance, especially considering that the AG concentrations in plasma of diabetic patients is mostly very low (0-10 mgIL). We also checked the substrate specificity of the color-developing reaction. D-Glucose, L-sorbose, D-xylose, and D-galactose were more or less responsive to the assay method. Accordingly, we had to remove these substances before enzymatic detection of AG with PROD.
Mini-Column Treatment
Glucose is the major substance in plasma responsive to the present enzymatic color-developing reaction (Table 1) . Using a solution of glucose and AG, we investigated various treatments for either selective removal of glucose or its conversion into a substance inert to PROD (data not shown). Namely, glucose was chemically reduced to sorbitol, enzymatically oxidized to glucono-S-lactone, enzymatically phosphorylated to glucose 6-phosphate, or physically adsorbed to resin. The physical adsorption by strongly basic anion-exchange resin (11, 12) was the most favorable in terms of capacity and selectivity: the resin adsorbed most sugars but not AG. We prepared mini-columns packed with strongly basic anion-exchange resin (OH-form). Strongly acidic cation-exchange resin (W form) was also added to the bottom of the column to neutralize the eluate.
Recovery ofAG from mini-column. To confirm recovery of AG from the mini-column, we applied AG standard solution to a mini-column and compared the eluate and noncolumn-treated AG solution by the enzymatic method (Table 2). The insignificant difference in the resulting absorbances between the AG standards treated with and without mini-column confirmed excellent recovery of AG in the column treatment.
Removal of other substrates with mini-column. The restilts for various sugars in the total assay system were compared with those obtained by omitting the mini-column treatment ( Table 1 ). All of the sugars that would interfere with the AG assay were completely trapped on the minicolumn, whereas sugar-alcohols, including AG and myoinositol, were quantitatively recovered from the column. Among the sugar alcohols examined (Table 1) , only myoinositol showed any possibility of interfering with the AG assay by the column/enzyme method. Fortunately, the influence of myo-inositol on the plasma AG assay is considered negligible because the plasma concentration of myoinositol is considerably less than AG; further, myo-i#{241}ositol is only 3% as reactive as AG toward PROD. In contrast, the assay of AG in urine was unsuccessful because of the higher concentration of myo-inositol in urine (Table 1) .
Application to Plasma Samples
When plasma samples were directly applied onto the mini-column, the column became clogged with plasma proteins. Therefore, we deproteinized the plasma by adding trichloroacetic acid before applying the column/enzyme method.
Precision. The within-day and day-to-day precisions (CV) of the column/enzyme method were 1.9-4.4% and 1.3-5.9%,
respectively, which appears acceptable compared with GLC method (Table 3) .
Analytical recovery. We performed analytical-recovery studies at three concentrations of AG in four plasma samples, one from a diabetic patient and three from normal individuals. The results were good (mean 100.4%) and acceptable for clinical application (Table 4) .
Interference. We did interference studies for endogenous substances and additives, examined in four plasmas of volunteers. Triolein emulsified with lecithin, used to assess the effect of chyle, had the most effect on the enzymatic system. Nonetheless, its addition at 41 g/L led to only a 5-9% overestimation of AG. Glucose up to 34 g/L, bilirubin at 0.23 g/L, ascorbic acid at 18 g/L, hemoglobin at 9.1 g/L, glutathione at 3.6 g/L, and uric acid at 1.7 g/L had no influence on observed AG values. Similarly, adding sodium citrate (18 g/L), sodium azide (9.1 g/L), heparin (91 units! mL), Na2EDTA (9.1 g/L) or sodium fluoride (8.3 g/L) also had no effect. We conclude that the combination of deproteinization and the de-ionization with the mini-column is very effective in removing interfering substances from the assay system.
Comparison of enzymatic and GLC methods. Assay of the concentration of AG in plasma or serum by GLC (4, 6, 7) was at one time the simplest and most reliable method. The AG values determined by the column/enzyme method (x) were compared with those determined by the GLC method (y). The regression equation was y = 1.062x -0.293 mg/L. The correlation was satisfactory, the intercept being close toO (r = 0.997, n = 49, S = 10.78); the shift from unity in the slope of the regression formula may be due to an overestimation of AG by the GLC method (7) . The precision of these two methods is also shown in Table 3 ; that of our enzyme method was acceptable and compared favorably with that of the GLC method.
Sample
Mean
Enzyme method decrease of plasma AG in diabetic rats was due to the urinary excretion of AG, which accompanied the urinary excretion of glucose (14).
We expect that AG will be widely used for diagnosis of SD CV, % diabetes mellitus and the column/enzyme method will be useful for measurement of AG. Now, we are trying to simplifr our method and to make an automatic system. Application to diagnosis of diabetes mellitus. We have tried to use our column/enzyme method for clinical diagnosin of diabetes mellitus; some of the results were reported by Yamanouchi et al. (13) . Briefly, AG was a good marker of diagnosis and compared favorably with glycated hemoglobin and fructosamine.
Within-run (n
AG concentrations in the nondiabetic normal humans approximated a gaussian distribution curve with mean ± SD of 24.6 ± 7.2 mg/L (n = 539), definitely different from that in diabetic patients (n = 808, 7.3 ± 7.1 mgfL). This agreed well with our previous results for AG measured by GLC (7) . Recently, we showed that the decrease of AG concentration in diabetic patients was associated with urinary excretion of glucose (5) , and the We thank Dr. Akio Tsuji and Dr. Masako Maeda (School of Pharmaceutical Sciences, Showa University) for their excellent advice on this work, and for correcting this manuscript.
